These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 31402119)
21. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease. Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216 [TBL] [Abstract][Full Text] [Related]
22. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models. Su C; Yang X; Lou J Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998 [TBL] [Abstract][Full Text] [Related]
23. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease. Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273 [TBL] [Abstract][Full Text] [Related]
24. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease. Esteves AR; Gozes I; Cardoso SM Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997 [TBL] [Abstract][Full Text] [Related]
25. Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates. Valdinocci D; Grant GD; Dickson TC; Pountney DL Mol Cell Neurosci; 2018 Jun; 89():80-94. PubMed ID: 29673913 [TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP/MPP+ via regulation of gene expression. Liu Y; Lu Z Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):841-848. PubMed ID: 29575151 [TBL] [Abstract][Full Text] [Related]
27. Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells. Wu F; Poon WS; Lu G; Wang A; Meng H; Feng L; Li Z; Liu S Brain Res; 2009 Oct; 1292():173-9. PubMed ID: 19646423 [TBL] [Abstract][Full Text] [Related]
29. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein. Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531 [TBL] [Abstract][Full Text] [Related]
30. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells. Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406 [TBL] [Abstract][Full Text] [Related]
31. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
32. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD. Chang C; Lang H; Geng N; Wang J; Li N; Wang X Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198 [TBL] [Abstract][Full Text] [Related]
33. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations. Sahay S; Ghosh D; Singh PK; Maji SK Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
35. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons. Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146 [TBL] [Abstract][Full Text] [Related]
36. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles. Hong Z; Tian C; Stewart T; Aro P; Soltys D; Bercow M; Sheng L; Borden K; Khrisat T; Pan C; Zabetian CP; Peskind ER; Quinn JF; Montine TJ; Aasly J; Shi M; Zhang J Neurology; 2021 May; 96(18):e2332-e2345. PubMed ID: 34032594 [TBL] [Abstract][Full Text] [Related]
37. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease. Thome AD; Standaert DG; Harms AS PLoS One; 2015; 10(10):e0140566. PubMed ID: 26469270 [TBL] [Abstract][Full Text] [Related]
38. Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide. Choi MG; Kim MJ; Kim DG; Yu R; Jang YN; Oh WJ PLoS One; 2018; 13(4):e0195339. PubMed ID: 29608598 [TBL] [Abstract][Full Text] [Related]
39. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach. Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009 [TBL] [Abstract][Full Text] [Related]
40. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease. Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]